Uric Acid and Diabetic Nephropathy Risk

Keyphrases

• Diabetic Nephropathy 100%
• Uric Acid Nephropathy 100%
• Diabetes 33%
• End-stage Renal Disease 33%
• Glomerular Filtration Rate 33%
• Uric Acid-lowering Therapy 33%
• Nephropathy Progression 33%
• Type 1 Diabetes Mellitus (T1DM) 22%
• Chronic Kidney Disease 22%
• Renin-angiotensin System Blockade 22%
• Allopurinol 22%
• Uric Acid 22%
• Renal Loss 22%
• Randomized Placebo-controlled Trial 11%
• Clinical Trials 11%
• Type I Diabetes 11%
• Type 2 Diabetes Mellitus (T2DM) 11%
• Clinical Manifestations 11%
• Glycemia 11%
• Blood Pressure 11%
• New Drug Targets 11%
• Treatment Methods 11%
• Reduction Method 11%
• Rate Reduction 11%
• Progression Rate 11%
• Iohexol 11%
• Current Treatment 11%
• Strong Predictor 11%
• Annual Incidence 11%
• Western World 11%
• Ongoing Trials 11%
• Loss Rate 11%
• Serum Uric Acid 11%
• Disease Case 11%
• Glomerular Filtration Rate Decline 11%

Medicine and Dentistry

• Diabetic Nephropathy 100%
• Uric Acid Nephropathy 100%
• Uric Acid 66%
• Glomerular Filtration Rate 44%
• Diabetes 33%
• End Stage Renal Disease 33%
• Insulin Dependent Diabetes Mellitus 22%
• Chronic Kidney Disease 22%
• Allopurinol 22%
• Renin Angiotensin Aldosterone System 22%
• Clinical Trial 11%
• Maturity Onset Diabetes of the Young 11%
• Blood Pressure 11%
• Iohexol 11%
• Placebo 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Uric Acid Nephropathy 100%
• Diabetic Nephropathy 100%
• Uric Acid 66%
• End Stage Renal Disease 33%
• Insulin Dependent Diabetes Mellitus 22%
• Chronic Kidney Failure 22%
• Allopurinol 22%
• Renin 22%
• Angiotensin 22%
• Clinical Trial 11%
• Placebo 11%
• Iohexol 11%
• Non Insulin Dependent Diabetes Mellitus 11%